HDAC1 |
HDAC1, RPD3L1: Histone deacetylase 1 |
TAL1 |
TAL1, SCL, TCL5: T-cell acute lymphocytic leukemia protein 1 |
2.757 |
Evidence |
|
FGR |
FGR, SRC2: Proto-oncogene tyrosine-protein kinase FGR |
CASP3 |
CASP3, CPP32: Caspase-3 precursor |
2.757 |
Evidence |
|
RGS19 |
RGS19, GAIP, GNAI3IP: Regulator of G-protein signaling 19 |
GSK3A |
GSK3A: Glycogen synthase kinase-3 alpha |
2.757 |
Evidence |
|
STAM2 |
STAM2: Signal transducing adapter molecule 2 |
EXOSC2 |
EXOSC2, RRP4: Exosome complex exonuclease RRP4 |
2.757 |
Evidence |
|
BRCA1 |
BRCA1, RNF53: Breast cancer type 1 susceptibility protein |
PCAF |
PCAF: Histone acetyltransferase PCAF |
2.757 |
Evidence |
|
NFKBIA |
NFKBIA, IKBA, MAD3, NFKBI: NF-kappa-B inhibitor alpha |
KPNA2 |
KPNA2, RCH1, SRP1: Importin subunit alpha-2 |
2.757 |
Evidence |
|
GIT1 |
GIT1: ARF GTPase-activating protein GIT1 |
NUP153 |
IPI00514528 |
2.757 |
Evidence |
|
PDPK1 |
PDPK1, PDK1: 3-phosphoinositide-dependent protein kinase 1 |
KCNA2 |
KCNA2: Potassium voltage-gated channel subfamily A member 2 |
2.752 |
Evidence |
|
ADRB2 |
ADRB2, ADRB2R, B2AR: Beta-2 adrenergic receptor |
OPRM1 |
OPRM1, MOR1: Mu-type opioid receptor |
2.752 |
Evidence |
|
PDPK1 |
PDPK1, PDK1: 3-phosphoinositide-dependent protein kinase 1 |
LIPE |
LIPE: Hormone-sensitive lipase |
2.752 |
Evidence |
|
BMP1 |
IPI00009054 |
MSN |
MSN: Moesin |
2.752 |
Evidence |
|
PDPK1 |
PDPK1, PDK1: 3-phosphoinositide-dependent protein kinase 1 |
GRIN2B |
GRIN2B, NMDAR2B: Glutamate [NMDA] receptor subunit epsilon-2 precursor |
2.752 |
Evidence |
|
TSHR |
IPI00386365 |
OPRM1 |
OPRM1, MOR1: Mu-type opioid receptor |
2.752 |
Evidence |
|
PDPK1 |
PDPK1, PDK1: 3-phosphoinositide-dependent protein kinase 1 |
RYR1 |
|
2.752 |
Evidence |
|
PDPK1 |
PDPK1, PDK1: 3-phosphoinositide-dependent protein kinase 1 |
HMGCR |
HMGCR: 3-hydroxy-3-methylglutaryl-coenzyme A reductase |
2.752 |
Evidence |
|
KCNQ2 |
KCNQ2: Potassium voltage-gated channel subfamily KQT member 2 |
IQGAP2 |
IQGAP2: Ras GTPase-activating-like protein IQGAP2 |
2.752 |
Evidence |
|
HBD |
HBD: Hemoglobin subunit delta |
HBB |
HBB: Hemoglobin subunit beta |
2.75 |
Evidence |
|
PDIA3 |
PDIA3, ERP57, ERP60, GRP58: Protein disulfide-isomerase A3 precursor |
B2M |
B2M, CDABP0092, HDCMA22P: Beta-2-microglobulin precursor [Contains: Beta-2-micro |
2.747 |
Evidence |
|
KIAA0117 |
RBM34, KIAA0117: RNA-binding protein 34 |
EIF3S10 |
EIF3S10, KIAA0139: Eukaryotic translation initiation factor 3 subunit 10 |
2.742 |
Evidence |
|
ABCD3 |
ABCD3, PMP70, PXMP1: ATP-binding cassette sub-family D member 3 |
MCM2 |
MCM2, BM28, CCNL1, CDCL1, KIAA0030: DNA replication licensing factor MCM2 |
2.74 |
Evidence |
|
SERPING1 |
SERPING1, C1IN, C1NH: Plasma protease C1 inhibitor precursor |
SLC37A4 |
G6PC, G6PT: Glucose-6-phosphatase |
2.735 |
Evidence |
|
F2 |
F2: Prothrombin precursor |
ASGR2 |
ASGR2: Asialoglycoprotein receptor 2 |
2.735 |
Evidence |
|
PROC |
PROC: Vitamin K-dependent protein C precursor |
ASGR2 |
ASGR2: Asialoglycoprotein receptor 2 |
2.735 |
Evidence |
|
MYH9 |
MYH9: Myosin-9 |
IQGAP1 |
IQGAP1, KIAA0051: Ras GTPase-activating-like protein IQGAP1 |
2.732 |
Evidence |
|
WASPIP |
IPI00552369 |
PRKCH |
PRKCH, PKCL, PRKCL: Protein kinase C eta type |
2.73 |
Evidence |
|